Effect of subtype selective nicotinic compounds on attention as assessed by the five-choice serial reaction time task

被引:208
作者
Grottick, AJ [1 ]
Higgins, GA [1 ]
机构
[1] F Hoffmann La Roche & Co Ltd, Div Pharma, Preclin CNS Res, CH-4070 Basel, Switzerland
关键词
nicotine; attention; five-choice serial reaction time task (5-CSRTT); alpha(4)beta(2); alpha(7); SIB1765F; AR-R; 17779; methyllycaconitine (MLA); di-hydro-beta-erythroidine (DH beta E); rat;
D O I
10.1016/S0166-4328(00)00305-3
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
Nicotine can improve attentional functioning in humans, and a number of studies have recently demonstrated that under specific task conditions, nicotine can also improve attention in the rat. Neuronal nicotinic receptors comprise combinations of alpha (2-9) and beta (2-4) subunits, arranged to form a pentameric receptor, with the principal CNS subtypes currently believed to be alpha (4)beta (2) and a homomeric alpha (7) receptor. In the present studies, we attempted to delineate the particular nicotinic receptor subtype(s) contributing to the effects of nicotine on attention by assessing various nicotinic ligands on performance in the five-choice serial reaction time task (5-CSRTT). In rats performing below criterion (< 80% correct, > 20% omissions to a 1-s visual stimulus), subchronic dosing with nicotine (0.2 mg/kg sc) and the alpha (4)beta (2) agonist SIE 1765F (5 mg/kg sc) increased correct responding and decreased response latencies across the treatment week; whereas the alpha (7) agonist AR-R 17779 (20 mg/kg sc) was without effect. In subjects meeting the criterion, the competitive high affinity (including alpha (4)beta (2)) nicotine receptor antagonist DH betaE (1-10 mg/kg sc) and the ct, antagonist methyllycaconitine (MLA: 5-10 mg/kg i.p.) did not disrupt performance, whereas at the highest dose, the non-competitive antagonist mecamylamine (0.3-3 mg/kg sc) decreased accuracy and increased response latencies. These changes bore some similarities to those of pre-feeding and the non-competitive NMDA antagonist dizocilpine (0.03-0.06 mg/kg sc), suggesting that mecamylamine-induced performance disruption may relate to non-nicotinic receptor effects. In subjects chronically treated with nicotine, acute nicotine challenge (0.4 mg/kg sc) significantly increased accuracy whilst having no effect on any other performance measures. Finally, in these same nicotine pre-treated rats, the decrease in latency and increase in premature responses induced by nicotine (0.2 mg/kg sc) to a target stimulus of 150 ms was fully antagonised by DH betaE (3 mg/kg sc) but not MLA (5 mg/kg i.p.). These results suggest that a, receptors do not play a role in any of the behavioural effects of nicotine observed in the 5-CSRTT, whereas a high affinity site, perhaps alpha (4)beta (2), is more likely involved. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:197 / 208
页数:12
相关论文
共 74 条
[1]   THE EFFECTS OF ACUTE AND REPEATED NICOTINE TREATMENT ON NUCLEUS-ACCUMBENS DOPAMINE AND LOCOMOTOR-ACTIVITY [J].
BENWELL, MEM ;
BALFOUR, DJK .
BRITISH JOURNAL OF PHARMACOLOGY, 1992, 105 (04) :849-856
[2]   The effect of repeated nicotine administration on the performance of drug-naive rats in a five-choice serial reaction time task [J].
Blondel, A ;
Simon, H ;
Sanger, DJ ;
Moser, P .
BEHAVIOURAL PHARMACOLOGY, 1999, 10 (6-7) :665-673
[3]   Characterisation of the effects of nicotine in the five-choice serial reaction time task in rats: antagonist studies [J].
Blondel, A ;
Sanger, DJ ;
Moser, PC .
PSYCHOPHARMACOLOGY, 2000, 149 (03) :293-305
[4]   EFFECTS OF LESIONS TO ASCENDING NORADRENERGIC NEURONS ON PERFORMANCE OF A 5-CHOICE SERIAL REACTION TASK IN RATS - IMPLICATIONS FOR THEORIES OF DORSAL NORADRENERGIC BUNDLE FUNCTION BASED ON SELECTIVE ATTENTION AND AROUSAL [J].
CARLI, M ;
ROBBINS, TW ;
EVENDEN, JL ;
EVERITT, BJ .
BEHAVIOURAL BRAIN RESEARCH, 1983, 9 (03) :361-380
[5]   SEROTONIN2 RECEPTOR AGONISTS AND SEROTONERGIC ANORECTIC DRUGS AFFECT RATS PERFORMANCE DIFFERENTLY IN A 5-CHOICE SERIAL REACTION-TIME-TASK [J].
CARLI, M ;
SAMANIN, R .
PSYCHOPHARMACOLOGY, 1992, 106 (02) :228-234
[6]  
ChavezNoriega LE, 1997, J PHARMACOL EXP THER, V280, P346
[7]   CHARACTERIZATION OF THE LOCOMOTOR STIMULANT ACTION OF NICOTINE IN TOLERANT RATS [J].
CLARKE, PBS ;
KUMAR, R .
BRITISH JOURNAL OF PHARMACOLOGY, 1983, 80 (03) :587-594
[8]   THE EFFECTS OF NICOTINE ON LOCOMOTOR-ACTIVITY IN NON-TOLERANT AND TOLERANT RATS [J].
CLARKE, PBS ;
KUMAR, R .
BRITISH JOURNAL OF PHARMACOLOGY, 1983, 78 (02) :329-337
[9]   AUTORADIOGRAPHIC EVIDENCE FOR NICOTINE RECEPTORS ON NIGROSTRIATAL AND MESOLIMBIC DOPAMINERGIC-NEURONS [J].
CLARKE, PBS ;
PERT, A .
BRAIN RESEARCH, 1985, 348 (02) :355-358
[10]   CENTRAL SYMPATHOMIMETIC ACTIVITY OF (+)-5-METHYL-10,11-DIHYDRO-5H-DIBENZO [A,D]CYCLOHEPTEN-5, 10-IMINE (MK-801), A SUBSTANCE WITH POTENT ANTICONVULSANT, CENTRAL SYMPATHOMIMETIC, AND APPARENT ANXIOLYTIC PROPERTIES [J].
CLINESCHMIDT, BV ;
MARTIN, GE ;
BUNTING, PR ;
PAPP, NL .
DRUG DEVELOPMENT RESEARCH, 1982, 2 (02) :135-145